Gene | Benign | Malignant | |||||
---|---|---|---|---|---|---|---|
Median | 25th | 75th | Median | 25th | 75th | p Value | |
VIL2, villin 2; COL8, collagen 8 alpha 1 subunit; CCNB1, G2/mitotic specific cyclin B1; HMG2, high mobility group protein; TSG101, TSG101 tumour susceptibility protein; CENP-F, CENP-F kinetochore protein; FAK, protein tyrosine kinase 2; DYRK2, protein kinase DYRK2. | |||||||
*Significant test result. | |||||||
CCNB1 | 0.76 | 0.25 | 1.62 | 8.97 | 4.67 | 13.01 | <0.001* |
CENP-F | 0.86 | 0.08 | 1.39 | 11.10 | 6.18 | 27.10 | <0.001* |
COL8 | 1.21 | 0.55 | 9.17 | 3.37 | 0.07 | 9.18 | 0.75 |
DYRK2 | 1.11 | 0.73 | 1.23 | 1.22 | 0.65 | 2.30 | 0.08 |
FAK | 0.97 | 0.21 | 3.00 | 13.30 | 2.55 | 27.19 | 0.003* |
HMG2 | 1.29 | 0.34 | 2.26 | 6.63 | 2.72 | 13.85 | 0.001* |
TSG101 | 0.91 | 0.75 | 2.09 | 2.73 | 1.94 | 3.67 | 0.024* |
VIL2 | 1.94 | 0.50 | 3.48 | 9.85 | 3.68 | 18.38 | <0.001* |